Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers

PURPOSE: Despite extensive biological and clinical studies, including comprehensive genomic and transcriptomic profiling efforts, pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease, with a poor survival and limited therapeutic options. The goal of this study was to assess co-expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantini, G., Vallés, A. M., Le Large, T. Y. S., Capula, M., Funel, N., Pham, T. V., Piersma, S. R., Kazemier, G., Bijlsma, M. F., Giovannetti, E., Jimenez, C. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716908/
https://www.ncbi.nlm.nih.gov/pubmed/32860207
http://dx.doi.org/10.1007/s13402-020-00548-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716908/
https://www.ncbi.nlm.nih.gov/pubmed/32860207
http://dx.doi.org/10.1007/s13402-020-00548-y

Ejemplares similares